Australian doctors believe they have found the key to eradicating Type 1 diabetes, the kind that obliges sufferers to regulate their blood glucose levels every day of their lives.
Read More »Diabetes In Control
Quick Pulse Before Exercise Linked to Death Risk
Heart rate changes in anticipation of exercise may predict sudden death cardiac risk, researchers said. A pulse that quickened during the mild mental stress just before an exercise stress test doubled the risk of sudden death later in life.
Read More »Lacosamide Safely Reduces Pain of Diabetic Neuropathy
The antiepileptic drug lacosamide is effective in reducing painful diabetic neuropathy without serious side effects, according to results from two phase 3 trials, one in the United States and one in the European Union, researchers reported at the American Academy of Neurology (AAN) 61st Annual Meeting.
Read More »Elevated Level of Protein in Urine Linked to Increased Risk for Blood Clots
According to a new study, preliminary research suggests that higher than normal levels of the protein albumin in urine is associated with an increased risk for blood clots in the deep veins of the legs or lungs (venous thromboembolism; VTE).
Read More »Understanding Medicare and Medicaid Coverage for Patients with Diabetes
Understanding Medicare and Medicaid Coverage for Patients with Diabetes. Part A, Part B, Part C, Part D … what do your patients choose for your diabetes supplies? Print out our easy to read handout to learn exactly what to do.
Read More »Issue 467 Newsflash
Disetronic Medical Systems Inc. and FDA have recalled some ACCU-CHEK Spirit insulin pumps. Hydroxycut Weight Loss Nutritional Products Recalled:
Read More »H1N1 (Swine Flu) Updated Key Points
If you want the current information on the H1N1 (Swine Flu), the CDC just issued a report with all the current, accurate and updated information, H1N1 Update
Read More »Glucose Targets Are the Least of Your Worries
Last week at The American College of Physicians Internal Medicine 2009 Conference everyone in hospital medicine seemed excited about inpatient glucose control. The NICE-SUGAR study drove interest and in a session on Friday morning Dr. Gregory A. Maynard, FACP, University of California, San Diego, weighed in on the subject.
Read More »FDA Extends Review Timeline for Onglyza/Saxagliptin by 90 Days
Bristol-Myers Squibb and Astra Zeneca reported last week that the FDA has determined it needs additional time to complete the review of the new drug application for Onglyza (saxagliptin)…
Read More »Aspirin Use Linked to a Lower Risk of Diabetes
Results of a new study recently published suggest an association between aspirin use and a decreased risk of developing Type 2 diabetes…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.